[OneMedForum] Senesco Technologies: Life and Death on a Cellular Level
“Programmed cell death” sounds a bit sinister, but it’s actually a normal and healthy process.
News
Chembio Diagnostics at the 2010 OneMedForum
Lawrence A. Siebert, President and CEO of Chembio Diagnostics, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
[OneMedForum] Micrus Endovascular: Help for Stroke Patients
Micrus Endovascular is the only publicly traded company focused on strokes.
Inovio BioMedical at the 2010 OneMedForum
Dr. Joseph Kim, CEO and President of Inovio Biomedical, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Vivostat at the 2010 OneMedForum
Michael Ruge, CEO of Vivostat A/S discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Advaxis at the 2010 OneMedForum
Thomas A. Moore, CEO of Advaxis, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Oculus Innovative Sciences at the 2010 OneMedForum
Hoji Alimi, Founder and CEO of Oculus Innovative Sciences, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
CytRx at the 2010 OneMedForum
Steven A. Kriegsman, President and CEO of CytRx, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
Dimera at the 2010 OneMedForum
Kent Hermsmeyer, PhD, President of Dimera Incorporated, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
Pressure BioSciences at the 2010 OneMedForum
Richard Schumacher, CEO of Pressure BioSciences, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.